Clinical trial NCT02308137 - References

Multiple Sclerosis, Secondary Progressive — Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)

Citation(s)

•   Franklin RJ, ffrench-Constant C, Edgar JM, Smith KJ
  Neuroprotection and repair in multiple sclerosis. Nat Rev Neurol. 2012 Nov 5;8(11):624-34. doi: 10.1038/nrneurol.2012.200. Epub 2012 Oct 2. Review.
•   Lassmann H, van Horssen J, Mahad D
  Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol. 2012 Nov 5;8(11):647-56. doi: 10.1038/nrneurol.2012.168. Epub 2012 Sep 25. Review.
•   Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG
  Multiple sclerosis. N Engl J Med. 2000 Sep 28;343(13):938-52. Review.
•   Nylander A, Hafler DA
  Multiple sclerosis. J Clin Invest. 2012 Apr;122(4):1180-8. doi: 10.1172/JCI58649. Epub 2012 Apr 2. Review.
•   Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Brück W, Lucchinetti C, Lassmann H
  Remyelination is extensive in a subset of multiple sclerosis patients. Brain. 2006 Dec;129(Pt 12):3165-72. Epub 2006 Aug 18. Erratum in: Brain. 2007 Mar;130(Pt 3):879.
•   Rovaris M, Confavreux C, Furlan R, Kappos L, Comi G, Filippi M
  Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol. 2006 Apr;5(4):343-54. Review.
•   Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, Lublin F, Miller A, Petkau J, Rao S, Reingold S, Syndulko K, Thompson A, Wallenberg J, Weinshenker B, Willoughby E
  Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol. 1997 Sep;42(3):379-82.
•   Tselis A, Khan OA, Lisak RP
  Approaches to neuroprotective strategies in multiple sclerosis. Expert Opin Pharmacother. 2010 Dec;11(17):2869-78. doi: 10.1517/14656566.2010.508070. Epub 2010 Aug 5. Review.
•   Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC
  The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain. 1989 Dec;112 ( Pt 6):1419-28.
•   Zhornitsky S, Yong VW, Weiss S, Metz LM
  Prolactin in multiple sclerosis. Mult Scler. 2013 Jan;19(1):15-23. doi: 10.1177/1352458512458555. Epub 2012 Aug 29. Review.

Open-label, Single-center, Single-arm Futility Trial Evaluating Oral Domperidone 10mg QID for Reducing Progression of Disability in Patients With Secondary Progressive Multiple Sclerosis (SPMS)

Details for clinical trial NCT02308137